TY - JOUR
T1 - Implementation of recommendations in rheumatic and musculoskeletal diseases
T2 - considerations for development and uptake
AU - Loza, Estibaliz
AU - Carmona, Loreto
AU - Woolf, Anthony
AU - Fautrel, Bruno
AU - Courvoisier, Delphine S
AU - Verstappen, Suzanne
AU - Aarrestad Provan, Sella
AU - Boonen, Annelies
AU - Vliet Vlieland, Thea
AU - Marchiori, Francesca
AU - Jasinski, Tiina
AU - Van der Elst, Kristien
AU - Ndosi, Mwidimi
AU - Dziedzic, Krysia
AU - Carrasco, Jose Miguel
N1 - © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/10
Y1 - 2022/10
N2 - A clinical guideline is a document with the aim of guiding decisions based on evidence regarding diagnosis, management and treatment in specific areas of healthcare. Specific to rheumatic and musculoskeletal diseases (RMDs), adherence to clinical guidelines recommendations impacts the outcomes of people with these diseases. However, currently, the implementation of recommendations is less than optimal in rheumatology.The WHO has described the implementation of evidence-based recommendations as one of the greatest challenges facing the global health community and has identified the importance of scaling up these recommendations. But closing the evidence-to-practice gap is often complex, time-consuming and difficult. In this context, the implementation science offers a framework to overcome this scenario.This article describes the principles of implementation science to facilitate and optimise the implementation of clinical recommendations in RMDs. Embedding implementation science methods and techniques into recommendation development and daily practice can help maximise the likelihood that implementation is successful in improving the quality of healthcare and healthcare services.
AB - A clinical guideline is a document with the aim of guiding decisions based on evidence regarding diagnosis, management and treatment in specific areas of healthcare. Specific to rheumatic and musculoskeletal diseases (RMDs), adherence to clinical guidelines recommendations impacts the outcomes of people with these diseases. However, currently, the implementation of recommendations is less than optimal in rheumatology.The WHO has described the implementation of evidence-based recommendations as one of the greatest challenges facing the global health community and has identified the importance of scaling up these recommendations. But closing the evidence-to-practice gap is often complex, time-consuming and difficult. In this context, the implementation science offers a framework to overcome this scenario.This article describes the principles of implementation science to facilitate and optimise the implementation of clinical recommendations in RMDs. Embedding implementation science methods and techniques into recommendation development and daily practice can help maximise the likelihood that implementation is successful in improving the quality of healthcare and healthcare services.
KW - ARTHRITIS
KW - CARE
KW - EDUCATION
KW - FACILITATORS
KW - GUIDELINE DISSEMINATION
KW - Health Care
KW - Health services research
KW - Outcome and Process Assessment
KW - Quality Indicators
U2 - 10.1136/ard-2022-223016
DO - 10.1136/ard-2022-223016
M3 - Editorial
C2 - 35961760
SN - 0003-4967
VL - 81
SP - 1344
EP - 1347
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 10
ER -